AllStripes is a healthcare technology company dedicated to unlocking new treatments for people with rare diseases. AllStripes has developed a technology platform that generates regulatory-ready evidence to accelerate rare disease research and drug development, as well as a patient application that empowers patients and families to securely participate in treatment research online and benefit from their own medical data. AllStripes was founded by CEO Nancy Yu and technology developer Onno Faber, following his diagnosis and journey with the rare disease neurofibromatosis type 2. The company is backed by Lux Capital, JAZZ Venture Partners, Spark Capital, Medidata Solutions, McKesson Ventures, Maveron, and a number of angel investors. For more information, visit www.allstripes.com.
Location: United States, California, San Francisco
Employees: 51-200
Phone: +1 415-404-9287
Total raised: $50M
Founded date: 2017
Investors 8
| Date | Name | Website |
| 28.01.2021 | Village Gl... | villageglo... |
| - | Garuda | garuda.vc |
| - | Burst Capi... | burst.vc |
| - | Shasta Ven... | shastavent... |
| 16.09.2020 | Lux Capita... | luxcapital... |
| 25.08.2021 | McKesson V... | ventures.m... |
| 01.09.2021 | JAZZ Ventu... | jazzvp.com |
| - | Spark Capi... | sparkcapit... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 24.08.2021 | Series B | $50M | - |
Mentions in press and media 12
| Date | Title | Description |
| 25.08.2021 | AllStripes Announces $50 Million Series B Financing to Advance Global Rare Disease Research | AllStripes, a healthcare technology company dedicated to unlocking treatments for people affected by rare diseases, announced the Company completed a $50 million Series B financing round. The financing was led by Lux Capital, a current inve... |
| 24.08.2021 | AllStripes lands $50M for tool that helps patients share medical data | Photo courtesy of AllStripes |
| 24.08.2021 | Why the end of Katerra doesn’t mean the end of construction tech investing | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. The high profile death of Katerra, a construction tech startup that aimed to slice and dice the c... |
| 24.08.2021 | Rare disease data-focused AllStripes raises $50M to enhance medical record mining | With the goal of launching 100 new digital research programs across different rare diseases, AllStripes has secured $50 million to intensify its efforts at collating medical records and searching them for insights that could aid in drug dev... |
| 24.08.2021 | AllStripes Secures $50M to Advance Global Rare Disease Research Platform | Nancy Yu, CEO and Co-founder, AllStripes – AllStripes, a San Francisco-based healthcare technology company dedicated to unlocking treatments for people affected by rare diseases, today announced it has raised $50 million in Series B funding... |
| 24.08.2021 | AllStripes Raises $50M in Series B Financing | Nancy Yu, AllStripes CEO and Co-founder AllStripes, a San Francisco, CA-based healthcare technology company dedicated to advancing treatments for people affected by rare diseases, raised $50m in Series B financing. The round was led by Lux ... |
| 24.08.2021 | AllStripes raises $50 million to support rare disease research | A startup that lets patients share their health records for rare disease research plans to expand its programs with an influx of funding. San Francisco-based AllStripes recently closed a $50 million series B round, led by Lux Capital. It pl... |
| 24.08.2021 | Why the end of Katerra doesn’t mean the end of construction tech investing | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Paid Content Takeda’s CEO on taking the Fortune Global 500 company into the future From Takeda Th... |
| 24.08.2021 | Rare disease data-focused AllStripes raises $50M to enhance medical record mining | With the goal of launching 100 new digital research programs across different rare diseases, AllStripes has secured $50 million to intensify its efforts at collating medical records and searching them for insights that could aid in drug dev... |
| 23.08.2021 | Lux Capital’s Deena Shakir is helping judge Startup Battlefield at this year’s Disrupt | Deena Shakir is a partner at Lux Capital, where she looks to invest in technologies that are streamlining analog industries while also improving lives and livelihoods. Among the companies she has backed, for example, are Shiru, which is lev... |
Show more